<?xml version="1.0" encoding="UTF-8"?>
<p>Between treatment initiation and the end of treatment (EoT), 4 (2.3%) of the 174 patients were LTFU, while 18 (10.3%) patients were LTFU after treatment completion; therefore, overall 22/174 (12.6%) patients were LTFU with no SVR12 test available.</p>
